Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aswini Balachandran

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 16, 2016
The efficacy and tolerability of mirabegron in a non-trial clinical settingAswini Balachandran, Jonathan Duckett
Neurourology and Urodynamics|February 22, 2017
The long term predictive value of preoperative pressure flow studies in the resolution of overactive bladder after insertion of a retropubic midurethral slingJonathan Duckett, Aswini Balachandran
International Urogynecology Journal|June 12, 2016
Does the diagnosis of detrusor overactivity affect the long-term prognosis of patients treated with a retropubic midurethral sling?Aswini Balachandran, Jonathan Duckett
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|May 4, 2017
Cystodistension: Is there evidence to support its use in current practice for patients with overactive bladder?Aswini Balachandran, Jonathan Duckett
International Urogynecology Journal|January 25, 2016
Tolerability and persistence in a large, prospective case series of women prescribed mirabegronJonathan Duckett, Aswini Balachandran
International Urogynecology Journal|November 23, 2014
What is the role of the multidisciplinary team in the management of urinary incontinence?Aswini Balachandran, Jonathan Duckett
International Urogynecology Journal|August 19, 2015
Is pretreatment cystometry important in predicting response to mirabegron in women with overactive bladder symptoms?Maya Basu, Aswini Balachandran, Jonathan Duckett
International Urogynecology Journal|December 17, 2014
The management of massive haematomas after insertion of retropubic mid-urethral slingsAswini Balachandran, Natasha Curtiss, Jonathan Duckett
International Urogynecology Journal|July 18, 2014
Third-line treatment for overactive bladder: should mirabegron be tried before intravesical botulinum toxin A therapy?Aswini Balachandran, Natasha Curtiss, Maya Basu, et al.
International Urogynecology Journal|April 26, 2017
Cystodistension versus cystoscopy in patients with refractory detrusor overactivity: a randomized controlled trialAswini Balachandran, Natasha Curtiss, Maya Basu, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
European Journal of Obstetrics, Gynecology, and Reproductive Biology|March 16, 2016
The efficacy and tolerability of mirabegron in a non-trial clinical settingAswini Balachandran, Jonathan Duckett
Neurourology and Urodynamics|February 22, 2017
The long term predictive value of preoperative pressure flow studies in the resolution of overactive bladder after insertion of a retropubic midurethral slingJonathan Duckett, Aswini Balachandran
International Urogynecology Journal|June 12, 2016
Does the diagnosis of detrusor overactivity affect the long-term prognosis of patients treated with a retropubic midurethral sling?Aswini Balachandran, Jonathan Duckett
Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology|May 4, 2017
Cystodistension: Is there evidence to support its use in current practice for patients with overactive bladder?Aswini Balachandran, Jonathan Duckett
International Urogynecology Journal|January 25, 2016
Tolerability and persistence in a large, prospective case series of women prescribed mirabegronJonathan Duckett, Aswini Balachandran
International Urogynecology Journal|November 23, 2014
What is the role of the multidisciplinary team in the management of urinary incontinence?Aswini Balachandran, Jonathan Duckett
International Urogynecology Journal|August 19, 2015
Is pretreatment cystometry important in predicting response to mirabegron in women with overactive bladder symptoms?Maya Basu, Aswini Balachandran, Jonathan Duckett
International Urogynecology Journal|December 17, 2014
The management of massive haematomas after insertion of retropubic mid-urethral slingsAswini Balachandran, Natasha Curtiss, Jonathan Duckett
International Urogynecology Journal|July 18, 2014
Third-line treatment for overactive bladder: should mirabegron be tried before intravesical botulinum toxin A therapy?Aswini Balachandran, Natasha Curtiss, Maya Basu, et al.
International Urogynecology Journal|April 26, 2017
Cystodistension versus cystoscopy in patients with refractory detrusor overactivity: a randomized controlled trialAswini Balachandran, Natasha Curtiss, Maya Basu, et al.
Pageof 2